基于囊泡的细胞外药物输送系统用于头部和部状细胞癌:系统性审查
Karolina Dżaman1, Katarzyna Czerwaty1
1Department of Otolaryngology, Centre of Postgraduate Medical Education, Marymoncka 99/103, 01-813 Warsaw, Poland.
Pharmaceutics
|May 27, 2023
概括
细胞外囊泡 (EVs) 有望通过帮助药物输送和调节瘤微环境来治疗头支状细胞癌 (HNSCC). 然而,研究还处于早期阶段,在EV隔离和HNSCC治疗标准化方面面临挑战.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 头角状细胞癌 (HNSCC) 每年在全球范围内影响超过89万个人.
- 目前的HNSCC治疗具有显著的副作用和功能缺陷,需要新的治疗方法.
研究的目的:
- 系统地审查细胞外囊泡 (EVs) 在头部和部状细胞癌 (HNSCC) 治疗中的新兴应用.
- 总结关于在HNSCC中使用EV用于药物输送,免疫调节,诊断,基因疗法和瘤微环境调节的当前知识.
主要方法:
- 在PubMed/MEDLINE,Scopus,Web of Science和Cochrane数据库中进行了系统的文献搜索,截至2022年12月11日.
- 包括全文原始研究论文在英语. 通过修改的OHAT偏差风险评级工具来评估研究质量.
- 在436个确定的记录中,有18个符合纳入的条件.
主要成果:
- 细胞外囊泡 (EVs) 对HNSCC提供各种治疗潜力,包括向药物输送和免疫系统调节.
- 该审查强调了HNSCC的EV研究的早期阶段,确定了EV隔离,净化和标准化的关键挑战.
结论:
- 电动汽车是创新的HNSCC疗法的一个有希望的前沿,尽管仍然存在重大研究障碍.
- 对EV隔离和治疗方案的标准化对于HNSCC治疗中的临床转化至关重要.
更多相关视频
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.9K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.6K
相关概念视频
Drug Delivery: Overview
333
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
333
Drug Delivery: Miscellaneous Routes
409
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
409
